Study Shows Gut Microbiota Diets Can Enhance the Effectiveness of Diabetes Medications
27th November, Hyderabad 2024: A first-of-its-kind clinical trial in India shows remarkable results for people with diabetes. The trial was conducted using BugSpeaks, a flagship technology of Leucine Rich Bio, India’s first microbiome-based company. BugSpeaks is a gut microbiome profiling test that provides nutritional recommendations based on the individual’s gut microbiota profile. With India being …
Read more “Study Shows Gut Microbiota Diets Can Enhance the Effectiveness of Diabetes Medications”